ESMO Events 2025

Meetings opens in new tab/window | ESMO opens in new tab/window

Welcome to our ESMO Virtual Congress site where we showcase the very best from ESMO's flagship portfolio.

ESMO Sarcoma and Rare Cancers Congress 2025 opens in new tab/window

Whether you are a seasoned oncologist, a dedicated researcher, a healthcare professional, a pharmaceutical industry leader, or a patient advocate, this event offers something for everyone committed to advancing the care and improving outcomes of patients with sarcomas and rare cancers. Below a collection of papers recently published in ESMO’s premier journals carefully selected to reflect the themes of the meeting.

Annals of Oncology

• A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse opens in new tab/window J.-Y. Blay; C. Schiffler; O. Bouché; M. Brahmi; F. Duffaud; M. Toulmonde; B. Landi; W. Lahlou; D. Pannier; E. Bompas; F. Bertucci; L. Chaigneau; O. Collard; M. Pracht; C. Henon; I. Ray-Coquard; K. Armoun; S. Salas; M. Spalato-Ceruso; A. Adenis; B. Verret; N. Penel; C. Moreau-Bachelard; A. Italiano; A. Dufresne; S. Metzger; S. Chabaud; D. Perol; A. Le Cesne

• Results of a phase Ib study of olaparib with concomitant radiotherapy in soft-tissue sarcoma: a French sarcoma group study opens in new tab/window P. Sargos, MD; M.P. Sunyach, MD; A. Ducassou, MD; C. Llacer, MD; D. Dinart, PhD; A. Michot, MD; T. Valentin, MD; N. Firmin, MD; J.Y. Blay, MD PhD; P. Gillon, MD; C. Bellera, PhD; A. Italiano, MD PhD

ESMO Open

• Efficacy, safety, and pharmacokinetics of eribulin as monotherapy or in combination with irinotecan for patients with pediatric rhabdomyosarcoma, non-rhabdomyosarcoma soft tissue sarcoma, or Ewing sarcoma opens in new tab/window M. Casanova; C.M. Albert; F. Bautista; S.C. Borinstein; S. Bradfield; A. Bukowinski; Q. Campbell-Hewson; D.S. Hawkins; A. Kim; G.M. Milano; L.V. Marshall; N. Pinto; C.A. Pratilas; A. Rubio-San-Simón; R. Windsor; O. Majid; R. Scott; Y. Jia; C. Paoletti; U. Kontny

• Genomic profiling of intimal sarcoma reveals molecular subtypes with distinct tumor microenvironments and therapeutic implications opens in new tab/window C. Park; R. Kim; J.M. Bae; T. Lee; S. Song; Y. Kwak; K.B. Lee; J. Youk; B. Keam; T.M. Kim; D.-W. Kim; J.-I. Kim; J. Choi; M. Kim

Immuno-Oncology and Technology

• Armoring chimeric antigen receptor (CAR) T cells as micropharmacies for cancer therapy opens in new tab/window C. Carcopino; E. Erdogan; M. Henrich; S. Kobold

• Durable complete response after combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus (TILT-123) in a patient with metastatic mucosal melanoma opens in new tab/window T.J. Monberg; T. Kudling; B. Albieri; S. Pakola; E. Ellebaek; M. Donia; R.L. Eefsen; C. von Buchwald; C. Kistler; J.M. Santos; J. Clubb; L. Haybout; M.C.W. Westergaard; D.C.A. Quixabeira; E. Jirovec; R. Havunen; S. Sorsa; V. Cervera-Carrascon; A. Hemminki; I.M. Svane

ESMO Gastrointestinal Oncology

• Gastrin-releasing peptide receptor expression in gastrointestinal stromal tumours opens in new tab/window M. Berndsen; F. Puls; A. Thornell; Y. Arvidsson; A. Muth; S. Lindskog; E. Elias

• Exploring the pathway: clinical utility and open challenges of targeting BRAF alterations in biliary tract cancers and gastrointestinal malignancies opens in new tab/window L. Weiss; D. Zhang; W.G. Kunz; S. Boeck; G. Curigliano; V. Subbiah; F. Lordick; T. Brummer; C.B. Westphalen; L. Boscolo Bielo

ESMO Real World Data and Digital Oncology

• Real-world treatment patterns and challenges of patients with biliary tract cancer: retrospective chart review survey in Europe (GARNET-2) opens in new tab/window J. Bridgewater; J. Sah; A. Szende; M. Paskow; P. Messina; B. Baur; J.M. Banales

• Head and Neck Sarcoma Assessor (HaNSA) for treatment decisions using real-world data opens in new tab/window M.Y.S. See; J.J.N. Goh; C.E. Low; C.E. Yau; W.S. Ong; R.X. Wong; N.F. Mohamed Noor; M.H.B.H. Mohamed; J.T. Suha; A.N.H. Sairi; W.L. Goh; X.Y. Woo; V.S. Yang

ESMO affiliated journals

• Neoadjuvant chemotherapy for radiation associated angiosarcoma (RAAS) of the breast: A retrospective single center study opens in new tab/window Stijn J.C. van der Burg; Sophie J.M. Reijers; Anke Kuijpers; Lotte Heimans; Astrid N. Scholten; Rick L.M. Haas; Hester van Boven; Willemijn M. Kolff; Marie-Jeanne T.F.D. Vrancken Peeters; Martijn Kerst; Beatrijs A. Seinstra; Neeltje Steeghs; Winette T.A. van der Graaf; Yvonne M. Schrage; Winan J. van Houdt

• Personalized treatment strategies for breast adenoid cystic carcinoma: A machine learning approach opens in new tab/window Sakhr Alshwayyat; Mahmoud Bashar Abu Al Hawa; Mustafa Alshwayyat; Tala Abdulsalam Alshwayyat; Siya sawan; Ghaith Heilat; Hanan M. Hammouri; Sara Mheid; Batool Al Shweiat; Hamdah Hanifa

• Functioning neuroendocrine tumors (NET): Minimum requirements for a NET specialist opens in new tab/window F. Spada; R.E. Rossi; R. Modica; F. Gelsomino; M. Rinzivillo; M. Rubino; E. Pisa; A.La Salvia; N. Fazio

• Primary mediastinal large B-cell Lymphoma: Biological features, clinical characteristics and current treatment strategies opens in new tab/window Livia Donzelli; Alice Di Rocco; Luigi Petrucci; Maurizio Martelli

• Primary pulmonary adenoid cystic carcinoma: A study of clinicopathological features and molecular alterations in twenty-one cases opens in new tab/window Zhiyuan Yao; Tong Qiu; Changlei Li; Weimao Kong; Guangqi Li; Peng Song; Guohua Wang; Wenjie Jiao

• Efficacy of immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma and predictive potential of mutated TP53 opens in new tab/window Mingying Wu; Na Zhou; Mei Guan; Yingyi Wang; Yuzhou Wang

• Clinical Impact of Next-Generation Sequencing of T-Cell Lymphomas: A Single Institution Experience opens in new tab/window Omar Elghawy; Julia Wang; Olivia J. Leung; Nishwant Swami; Veronica Carvajal; Guang Yang; Daniel J. Landsburg; Jakub Svoboda; Sunita D. Nasta; Elise A. Chong; Stephen J. Schuster; Colin J. Thomas; Jordan S. Carter; Adam Bagg; Stefan K. Barta

• A Real-World Evaluation of Frontline Treatment for Acute Myeloid Leukemia With Azacitidine Plus Venetoclax opens in new tab/window Joseph Brandwein; David Page; Elena Liew; Mark Hnatiuk; Lauren Bolster; Marlene Hamilton; Daniel Sawler; Peng Wang

ESMO's Journal Portfolio

While diverse in nature and in content, these journals offer ESMO members and the oncology community a highly visible platform to publish important scientific studies, and a highly credible source for educational updates. Elsevier is the proud publisher of Annals of Oncology, Immuno-Oncology and Technology (IOTECH), ESMO Open, ESMO Gastrointestinal Oncology, ESMO Real World Data and Digital Oncology, ESMO Rare Cancers, and ESMO Affiliated Journals The Breast, Lung Cancer, Cancer Treatment Reviews and Clinical Lymphoma Myeloma and Leukemia.